Back to trial detailsIntake questionnaire
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Applying to University of Iowa Hospitals and Clinics · Iowa City, Iowa
Answer a few short questions to share with the research team.
0 of 4 answered